tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OCUL Stock Latest News

Ocular Therapeutix (NASDAQ:OCUL): Promising Treatment Fuels Growth Potential
Market NewsOcular Therapeutix (NASDAQ:OCUL): Promising Treatment Fuels Growth Potential
16d ago
OCUL
Ocular Therapeutix upgraded to Buy at TD Cowen with SOL-1 trial ‘going great’
PremiumThe Fly
Ocular Therapeutix upgraded to Buy at TD Cowen with SOL-1 trial ‘going great’
16d ago
OCUL
Ocular Therapeutix upgraded to Buy from Hold at TD Cowen
PremiumThe Fly
Ocular Therapeutix upgraded to Buy from Hold at TD Cowen
16d ago
OCUL
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
19d ago
BPTH
CABA
Ocular provided positive update on enrollment, says Piper Sandler
PremiumThe Fly
Ocular provided positive update on enrollment, says Piper Sandler
22d ago
OCUL
Ocular Therapeutix Shareholders Approve Expansion and Leadership Changes
PremiumCompany AnnouncementsOcular Therapeutix Shareholders Approve Expansion and Leadership Changes
22d ago
8K
OCUL
Ocular Therapeutix: Progress made with AXPAXLI SOL-1 for wet AMD
PremiumThe Fly
Ocular Therapeutix: Progress made with AXPAXLI SOL-1 for wet AMD
23d ago
OCUL
Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Study (SOL-R) in wet AMD at Investor Day, Along with Positive 48-week Data from HELIOS NPDR Study
PremiumPress Releases
Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Study (SOL-R) in wet AMD at Investor Day, Along with Positive 48-week Data from HELIOS NPDR Study
23d ago
OCUL
Ocular Therapeutix to hold investor day
PremiumThe Fly
Ocular Therapeutix to hold investor day
24d ago
OCUL
Adverum Biotechnologies appoints Ozden as CMO, Kiss to board of directors
PremiumThe Fly
Adverum Biotechnologies appoints Ozden as CMO, Kiss to board of directors
25d ago
ADVM
OCUL
Ocular Therapeutix® to Host Investor Day on June 13, 2024
PremiumPress Releases
Ocular Therapeutix® to Host Investor Day on June 13, 2024
1M ago
OCUL
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1M ago
OCUL
Ocular Therapeutix to eliminate 13% of company’s workforce
PremiumThe FlyOcular Therapeutix to eliminate 13% of company’s workforce
1M ago
OCUL
Ocular Therapeutix transferred with Overweight rating at Piper Sandler
PremiumThe Fly
Ocular Therapeutix transferred with Overweight rating at Piper Sandler
1M ago
OCUL
Ocular Therapeutix price target lowered to $7 from $11 at TD Cowen
PremiumThe Fly
Ocular Therapeutix price target lowered to $7 from $11 at TD Cowen
2M ago
OCUL
Ocular Therapeutix price target lowered to $22 from $24 at JMP Securities
PremiumThe Fly
Ocular Therapeutix price target lowered to $22 from $24 at JMP Securities
2M ago
OCUL
Ocular Therapeutix price target lowered to $14 from $16 at H.C. Wainwright
PremiumThe Fly
Ocular Therapeutix price target lowered to $14 from $16 at H.C. Wainwright
2M ago
OCUL
Ocular Therapeutix reports Q1 EPS (49c), consensus (19c)
PremiumThe Fly
Ocular Therapeutix reports Q1 EPS (49c), consensus (19c)
2M ago
OCUL
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2M ago
OCUL
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
PremiumPress ReleasesOcular Therapeutix™ to Present at Two Upcoming Investor Conferences
2M ago
OCUL
Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024
PremiumPress Releases
Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024
2M ago
OCUL
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024
PremiumPress Releases
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024
2M ago
OCUL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >